ArticleCancers2018

Construction and Characterization of a Humanized Anti-Epstein-Barr Virus gp350 Antibody with Neutralizing Activity in Cell Culture.

Jerome E Tanner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.